secwatch.observer — SEC 8-K summary
======================================

Issuer:     ALNYLAM PHARMACEUTICALS, INC. (ALNY)
CIK:        0001178670
Form:       8-K
Filed at:   2023-01-06T23:59:59+00:00
Accession:  0001193125-23-003554
Event type: leadership
Sentiment:  positive
Materiality: 0.40
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alnylam appoints Nobel laureate Carolyn Bertozzi to board; Amy Schulman becomes Chair
--------------------------------------------------------------------------------

- Carolyn Bertozzi, Ph.D., Nobel laureate in chemistry, elected to Board effective Jan. 5, 2023.
- Bertozzi receives $55,000 annual cash retainer and option for 4,268 shares at $225.68.
- Michael W. Bonney steps down as Executive Chair, continues as non-independent director.
- Lead Independent Director Amy W. Schulman appointed Chair of the Board.
- Board expands from 11 to 12 directors; Bertozzi to serve as Class III director until 2025 annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1178670/000119312523003554/0001193125-23-003554-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1178670/000119312523003554/d426017d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-003554

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer